GALMED PHARMACEUTICALS LTD's ticker is GLMD and the CUSIP is M47238106. A total of 26 filers reported holding GALMED PHARMACEUTICALS LTD in Q2 2021. The put-call ratio across all filers is 2.05 and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q1 2021 | $634,000 | +10.3% | 184,927 | 0.0% | 0.00% | +50.0% |
| Q4 2020 | $575,000 | -20.7% | 184,927 | -10.0% | 0.00% | -33.3% |
| Q3 2020 | $725,000 | -29.7% | 205,375 | -4.7% | 0.00% | -40.0% |
| Q2 2020 | $1,031,000 | +38.2% | 215,594 | 0.0% | 0.01% | 0.0% |
| Q1 2020 | $746,000 | -40.1% | 215,594 | 0.0% | 0.01% | -28.6% |
| Q4 2019 | $1,246,000 | +20.9% | 215,594 | 0.0% | 0.01% | 0.0% |
| Q3 2019 | $1,031,000 | -35.0% | 215,594 | 0.0% | 0.01% | -36.4% |
| Q2 2019 | $1,585,000 | -10.0% | 215,594 | 0.0% | 0.01% | 0.0% |
| Q1 2019 | $1,761,000 | +19.6% | 215,594 | 0.0% | 0.01% | -8.3% |
| Q4 2018 | $1,473,000 | -66.5% | 215,594 | -33.5% | 0.01% | -58.6% |
| Q3 2018 | $4,401,000 | -41.9% | 324,094 | -49.1% | 0.03% | -49.1% |
| Q2 2018 | $7,570,000 | – | 636,140 | – | 0.06% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Ibex Investors LLC | 965,000 | $3,339,000 | 3.36% |
| BVF INC/IL | 1,832,484 | $6,340,000 | 0.59% |
| P.A.W. CAPITAL CORP | 100,000 | $346,000 | 0.47% |
| Voss Capital, LLC | 159,454 | $319,000 | 0.43% |
| 683 Capital Management, LLC | 1,563,640 | $5,412,000 | 0.32% |
| Vivo Capital, LLC | 860,103 | $2,976,000 | 0.27% |
| Rock Creek Group, LP | 94,454 | $327,000 | 0.18% |
| Nantahala Capital Management | 1,303,652 | $4,511,000 | 0.17% |
| Phoenix Holdings Ltd. | 75,383 | $253,000 | 0.01% |
| ARK Investment Management | 88,243 | $305,000 | 0.01% |